MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-118
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK

Clinical Cancer Research
Cancer ResearchOncology
2014English

Ras Inhibition Induces Insulin Sensitivity and Glucose Uptake

PLoS ONE
Multidisciplinary
2011English

RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

Oligosaccharyltransferase Inhibition Induces Senescence in RTK-driven Tumor Cells

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Nature
Multidisciplinary
2013English

MEK Inhibition Appears to Improve Symptom Control in Primary NRAS-driven CNS Melanoma in Children

British Journal of Cancer
Cancer ResearchOncology
2017English

Inhibition of Protein Kinase C Induces Differentiation in Neuro-2a Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Adipocyte-Like Differentiation in a Posttreatment Embryonal Rhabdomyosarcoma

Case Reports in Pathology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy